Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026)
Insulet (PODD) posted Depreciation & Amortization (CF) of $26.2 million for Q1 2026, up 7.38% on a QoQ basis from $24.4 million in Q4 2025, and up 20.74% year-over-year from $21.7 million in Q1 2025.
Insulet (PODD) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends
Insulet's Depreciation & Amortization (CF) history runs 17 years deep, the most recent figure standing at $26.2 million for Q1 2026.
- Quarterly Depreciation & Amortization (CF) rose 20.74% year-over-year to $26.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $94.9 million (up 13.38% YoY) and the FY2025 annual result came in at $90.4 million, up 11.88% from the prior year.
- Depreciation & Amortization (CF) was $26.2 million for Q1 2026 at Insulet, up from $24.4 million in the prior quarter.
- Across five years, Depreciation & Amortization (CF) topped out at $26.2 million in Q1 2026 and bottomed at $15.3 million in Q1 2022.
- A 5-year average of $19.6 million and a median of $18.8 million in 2023 frame the typical range for Depreciation & Amortization (CF).
- Annual changes were most pronounced in 2025 — Depreciation & Amortization (CF) rose 3.29% — and 2026, when it advanced 20.74%.
- Insulet's Depreciation & Amortization (CF) stood at $16.2 million in 2022, then gained by 16.05% to $18.8 million in 2023, then gained by 14.36% to $21.5 million in 2024, then climbed by 13.49% to $24.4 million in 2025, then gained by 7.38% to $26.2 million in 2026.
- Business Quant data shows PODD's Depreciation & Amortization (CF) at $26.2 million in Q1 2026, $24.4 million in Q4 2025, and $22.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.86 Bn | 175.56 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 128.95 Bn | 126.07 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 108.31 Bn | 99.09 Bn | 6.41 Bn | 716.00 Mn |
| 4 | Boston Scientific | 68.46 Bn | 67.01 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 48.25 Bn | 44.58 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Dexcom | 28.35 Bn | 27.23 Bn | 750.30 Mn | 67.10 Mn |
| 7 | GE HealthCare Technologies | 28.05 Bn | 25.76 Bn | 1.98 Bn | 78.00 Mn |
| 8 | Smith & Nephew | 26.96 Bn | 26.38 Bn | - | - |
| 9 | Koninklijke Philips | 24.06 Bn | 20.93 Bn | 2.07 Bn | 310.25 Mn |
| 10 | Insulet | 11.61 Bn | 11.13 Bn | 529.10 Mn | 26.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 26.20 Mn |
| Mar 31, 2026 | 26.20 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Dec 31, 2025 | 24.40 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Sep 30, 2025 | 22.00 Mn |
| Jun 30, 2025 | 22.30 Mn |
| Jun 30, 2025 | 22.30 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Mar 31, 2025 | 21.70 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Dec 31, 2024 | 21.50 Mn |
| Sep 30, 2024 | 21.30 Mn |
| Sep 30, 2024 | 21.30 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Jun 30, 2024 | 19.20 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Mar 31, 2024 | 18.80 Mn |
| Dec 31, 2023 | 18.80 Mn |
| Dec 31, 2023 | 18.80 Mn |